Every financial statement,
one clean chart.
Search any US-listed company. Data straight from SEC filings.
REPLIGEN CORP (RGEN), most recent 12 months reported: revenue $785.1M, net income $41.54M, free cash flow $110.15M. Latest balance sheet on file: liquid cash $810.45M, total debt $551.05M, net cash $259.4M. From SEC filings. More on REPLIGEN CORP: Revenue · Profitability · Cash flow · Debt Others in Biological Products, (No Diagnostic Substances): QIAGEN N.V. · HALOZYME THERAPEUTICS, INC. · BIO-TECHNE Corp · BIOCRYST PHARMACEUTICALS, INC. · TARSUS PHARMACEUTICALS, INC. · ADMA BIOLOGICS, INC. · Krystal Biotech, Inc. · Twist Bioscience Corporation
Filter every US company by the numbers — net cash, margins, ROIC, growth. Looking for one company? The search box above is free.
Follow a company and we'll email you when it files a quarterly or annual report with the SEC. Free follows 3 companies; Pro follows up to 500, and sorts and filters them.